The Phosphodiesterase Type IV Inhibitor Cilomilast Decreases Pro-inflammatory Cytokine Production From Primary Bronchial Epithelial Cells in Lung Transplantation Patients

Journal of Heart and Lung Transplantation

Volumn 25, Issue 12, 2006, Pages 1436-1440

  Murphy, Des M ^a   Ward, Chris ^a   Forrest, Ian A ^a   Pritchard, Gail ^a   Jones, Debbie ^b   Stovold, Rachel ^a   Fisher, Andrew J ^a   Cawston, Tim E ^b   Lordan, Jim L ^a   Corris, Paul A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CILOMILAST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; VASCULOTROPIN;

ALLOGRAFT; ARTICLE; BRONCHUS; BRONCHUS MUCOSA; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; LUNG TRANSPLANTATION; PRIORITY JOURNAL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BRONCHI; CARBOXYLIC ACIDS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG TRANSPLANTATION; NITRILES; PHOSPHODIESTERASE INHIBITORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845441656     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.09.005     Document Type: Article

References (23)

1. Boehler A., and Estenne M. Posttransplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
2. Verleden G.M., and Dupont L.J. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 77 (2004) 1465-1467
3. Yates B., Murphy D.M., Forrest I.A., et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 172 (2005) 772-775
4. Gerhardt S.G., McDyer J.F., Girgis R.E., Conte J.V., Yang S.C., and Orens J.B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 168 (2003) 121-125
5. Fan Chung K. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 533 (2006) 110-117
6. Forrest I.A., Murphy D.M., Ward C., et al. Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J 26 (2005) 1080-1085
7. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
8. British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of Standards of Care Committee of British Thoracic Society. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 56 Suppl 1 (2001) i1-i21
9. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
10. Oliver M.H., Harrison N.K., Bishop J.E., Cole P.J., and Laurent G.J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci 92 (1989) 513-518
11. Torphy T.J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157 (1998) 351-370
12. Mata M., Sarria B., Buenestado A., Cortijo J., Cerda M., and Morcillo E.J. Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells. Thorax 60 (2005) 144-152
13. Dowling R.B., Johnson M., Cole P.J., and Wilson R. The effect of rolipram, a type IV phosphodiesterase inhibitor, on Pseudomonas aeruginosa infection of respiratory mucosa. J Pharmacol Exp Ther 282 (1997) 1565-1571
14. Riise G.C., Williams A., Kjellstrom C., Schersten H., Andersson B.A., and Kelly F.J. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J 12 (1998) 82-88
15. Ward C., Snell G.I., Zheng L., et al. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med 158 (1998) 84-91
16. Whitford H., Orsida B., Kotsimbos T., et al. Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids. Ann Transplant 5 (2000) 31-37
17. Zheng L., Walters E.H., Ward C., et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 55 (2000) 53-59
18. Zheng L., Ward C., Snell G.I., et al. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am J Respir Crit Care Med 155 (1997) 2072-2077
19. Zheng L., Orsida B.E., Ward C., et al. Airway vascular changes in lung allograft recipients. J Heart Lung Transplant 18 (1999) 231-238
20. Belperio J.A., Keane M.P., Burdick M.D., et al. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 115 (2005) 1150-1162
21. Strieter R.M. Masters of angiogenesis. Nat Med 11 (2005) 925-927
22. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., and Belperio J.A. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 27 (2006) 27
23. Hamilton J.A., and Anderson G.P. GM-CSF Biology. Growth Factors 22 (2004) 225-231